BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17850776)

  • 1. ERK signaling is a central regulator for BMP-4 dependent capillary sprouting.
    Zhou Q; Heinke J; Vargas A; Winnik S; Krauss T; Bode C; Patterson C; Moser M
    Cardiovasc Res; 2007 Dec; 76(3):390-9. PubMed ID: 17850776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BMPER is an endothelial cell regulator and controls bone morphogenetic protein-4-dependent angiogenesis.
    Heinke J; Wehofsits L; Zhou Q; Zoeller C; Baar KM; Helbing T; Laib A; Augustin H; Bode C; Patterson C; Moser M
    Circ Res; 2008 Oct; 103(8):804-12. PubMed ID: 18787191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism and synergy between extracellular BMP modulators Tsg and BMPER balance blood vessel formation.
    Heinke J; Juschkat M; Charlet A; Mnich L; Helbing T; Bode C; Patterson C; Moser M
    J Cell Sci; 2013 Jul; 126(Pt 14):3082-94. PubMed ID: 23641068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
    Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA
    Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone morphogenetic protein-9 activates Smad and ERK pathways and supports human osteoclast function and survival in vitro.
    Fong D; Bisson M; Laberge G; McManus S; Grenier G; Faucheux N; Roux S
    Cell Signal; 2013 Apr; 25(4):717-28. PubMed ID: 23313128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelium-derived nitric oxide (NO) activates the NO-epidermal growth factor receptor-mediated signaling pathway in bradykinin-stimulated angiogenesis.
    Moraes MS; Costa PE; Batista WL; Paschoalin T; Curcio MF; Borges RE; Taha MO; Fonseca FV; Stern A; Monteiro HP
    Arch Biochem Biophys; 2014 Sep; 558():14-27. PubMed ID: 24960080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of exogenous angiotensin II stress-induced damage and apoptosis in human vascular endothelial cells via microRNA-155 expression.
    Liu T; Shen D; Xing S; Chen J; Yu Z; Wang J; Wu B; Chi H; Zhao H; Liang Z; Chen C
    Int J Mol Med; 2013 Jan; 31(1):188-96. PubMed ID: 23174997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of the signal transduction pathways for VEGF-induced MAPKs activation in human vascular endothelial cells.
    Yashima R; Abe M; Tanaka K; Ueno H; Shitara K; Takenoshita S; Sato Y
    J Cell Physiol; 2001 Aug; 188(2):201-10. PubMed ID: 11424087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERK and Smads: getting together for angiogenic sprouting.
    Rizzo MT
    Cardiovasc Res; 2007 Dec; 76(3):375-6. PubMed ID: 17942085
    [No Abstract]   [Full Text] [Related]  

  • 10. Bone morphogenetic protein activities are enhanced by 3',5'-cyclic adenosine monophosphate through suppression of Smad6 expression in osteoprogenitor cells.
    Sugama R; Koike T; Imai Y; Nomura-Furuwatari C; Takaoka K
    Bone; 2006 Feb; 38(2):206-14. PubMed ID: 16203197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
    Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
    Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatase-mediated crosstalk control of ERK and p38 MAPK signaling in corneal epithelial cells.
    Wang Z; Yang H; Tachado SD; Capó-Aponte JE; Bildin VN; Koziel H; Reinach PS
    Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5267-75. PubMed ID: 17122112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractalkine-induced endothelial cell migration requires MAP kinase signaling.
    Volin MV; Huynh N; Klosowska K; Reyes RD; Woods JM
    Pathobiology; 2010; 77(1):7-16. PubMed ID: 20185962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hierarchical order of factors in the generation of FLK1- and SCL-expressing hematopoietic and endothelial progenitors from embryonic stem cells.
    Park C; Afrikanova I; Chung YS; Zhang WJ; Arentson E; Fong Gh Gh; Rosendahl A; Choi K
    Development; 2004 Jun; 131(11):2749-62. PubMed ID: 15148304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein-2 induces proinflammatory endothelial phenotype.
    Csiszar A; Ahmad M; Smith KE; Labinskyy N; Gao Q; Kaley G; Edwards JG; Wolin MS; Ungvari Z
    Am J Pathol; 2006 Feb; 168(2):629-38. PubMed ID: 16436676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.
    Yang X; Long L; Southwood M; Rudarakanchana N; Upton PD; Jeffery TK; Atkinson C; Chen H; Trembath RC; Morrell NW
    Circ Res; 2005 May; 96(10):1053-63. PubMed ID: 15845886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic AMP-dependent, protein kinase A-independent activation of extracellular signal-regulated kinase 1/2 following adenosine receptor stimulation in human umbilical vein endothelial cells: role of exchange protein activated by cAMP 1 (Epac1).
    Fang Y; Olah ME
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1189-200. PubMed ID: 17565009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
    Wen-Sheng W
    Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP).
    Fiori JL; Billings PC; de la Peña LS; Kaplan FS; Shore EM
    J Bone Miner Res; 2006 Jun; 21(6):902-9. PubMed ID: 16753021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNAi-mediated MEK1 knock-down prevents ERK1/2 activation and abolishes human hepatocarcinoma growth in vitro and in vivo.
    Gailhouste L; Ezan F; Bessard A; Frémin C; Rageul J; Langouët S; Baffet G
    Int J Cancer; 2010 Mar; 126(6):1367-77. PubMed ID: 19816936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.